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ABSTRACT
Background. Although it is broadly accepted that clinicians should endeavour to
reassure patients with low back pain, to do so can present a significant clinical challenge.
Guidance for how to provide effective reassurance is scarce and there may be a need
to counter patient concerns arising from misinterpretation of spinal imaging findings.
‘GLITtER’ (Green Light Imaging Intervention to Enhance Recovery) was developed as a
standardisedmethod of communicating imaging findings in amanner that is reassuring
and promotes engagement in an active recovery. This feasibility study is an important
step towards definitive testing of its effect.
Methods. This feasibility study was a prospective, quasi-randomised, parallel trial with
longitudinal follow-up, involving sampling of patients attending a spinal outpatient
clinic at a metropolitan hospital. English speaking adults (18–75 years) presenting to
the clinic with low back pain and prior spinal imaging were considered for inclusion.
Eligible patients were allocated to receive a GLITtER consultation or a standard
consultation (as determined by appointment scheduling and clinician availability), and
were blinded to their allocation. Full details of the GLITtER intervention are described
in accordance with the Tidier template. Follow-up data were collected after 1 and 3
months. The primary outcome of this study was the fulfillment of specific feasibility
criteria which were established a priori. Determination of a sample size for a definitive
randomised controlled trial was a secondary objective.
Results. Two hundred seventy-six patients underwent preliminary screening and 31
patients met the final eligibility criteria for study inclusion. Seventeen participants were
allocated to the intervention group and 14 were allocated to the control group. Three
month follow-up data were available from 42% of the 31 enrolled participants (N = 13,
six intervention, seven control). Feasibility indicators for consent, resource burden and
acceptability of the GLITtER intervention were met, however participant recruitment
was slower than anticipated and an acceptable follow-up rate was not achieved.
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Conclusions. Failure to achieve pre-specified recruitment and follow-up rates were
important outcomes of this feasibility study.We attribute failure to issues that are likely
to be relevant for other clinical trials with this population. It is realistic to consider
that these challenges can be overcome through careful strategy, ample funding and
continued partnership with health care providers.
Trial registration. The trial was registered on the Australian and New Zealand Clinical
Trials Registry on 28/2/2017 (ACTRN12617000317392).
Subjects Clinical Trials, Orthopedics
Keywords Low back pain, Reassurrance, Spinal imaging, Education, Conservative management,
Secondary care, Physiotherapy
INTRODUCTION
Patients with low back pain (LBP) attending secondary care settings can be characterised
by high pain intensity, poor function and higher frequency of poor prognosis than
patients attending primary care (Karran et al., 2017b; Morsø, et al., 2013; Morsø, et al.,
2014). Consequently, their contribution to the massive burden of LBP (Vos et al., 2016)
is likely to be significant. General practitioners (GPs) frequently refer their patients to
specialist secondary care clinics for surgical opinion (ABS, 2015; Coulter, 1998)—however
surgery is recommended for only a small proportion of cases (Li & Yen, 2010; Robarts et
al., 2017). For the remainder, clinicians are generally challenged to provide time-efficient,
guideline-based, conservative care recommendations. Screening tools have been used to
determine risk and optimal pathways for back pain patients in primary care, but systematic
review data (Karran et al., 2017a) are underwhelming and they seem to offer little benefit
within the context of secondary care (Karran et al., 2017b).
There is widespread current agreement in LBP clinical practice guidelines that clinicians
should deliver high quality information as a key component of their management
(O’Connell et al., 2016; Wong et al., 2017). In particular, patients should be reassured
that their condition is not likely to be serious, that a favourable outcome is usual and that
activity levels should be resumed as soon as possible (NICE, 2016; Koes et al., 2010; Qaseem
et al., 2017; Stochkendahl et al., 2017).While patient reassurance can be considered a central
tenet of this approach, practical guidance for how to effectively deliver reassurance in the
clinical setting is lacking (Hasenbring & Pincus, 2015; Traeger et al., 2015). Furthermore,
the impact of providing reassuring information on pragmatic outcomes appears to be
poorly understood (Pincus & McCracken, 2013; Traeger et al., 2017).
Counter to clinicians’ efforts to reassure, the communication of spinal imaging findings
have been suggested to have the potential to increase patients’ fear of re-injury and
reduce their likelihood of a good outcome (Roland & Van Tulder, 1998). Adverse effects
of early imaging of the lumbar spine have also been reported (Graves et al., 2012; Webster
& Cifuentes, 2010). That most LBP patients attending secondary care present with spinal
images (Sears et al., 2016) and that these images are routinely considered during the
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consultation, provides opportunity for careful consideration of how imaging results are
interpreted and communicated in this setting.
Recent evidence reveals a high prevalence of common degenerative features in the
imaging reports of asymptomatic adults (Brinjikji et al., 2014). This indicates that many
of these features—particularly when found incidentally—should not be considered
pathological and instead be regarded as normal age-related changes. Coherent with this
interpretation is that degenerative findings have been found to be poorly associated with
current pain (Brinjikji et al., 2014; Carragee et al., 2006; Suri et al., 2014) and prognosis
(Carragee et al., 2005; De Schepper et al., 2016; Jensen et al., 2014; Steffens et al., 2014).
Considering this evidence, we developed and tested an intervention framework based on
using imaging findings for clinical benefit (Karran et al., 2018). This psycho-educational
intervention, referred to as ‘GLITtER’ (Green Light Imaging Intervention to Enhance
Recovery), involves a standardised method of communicating radiological findings in a
manner designed to reassure patients and promote engagement in an active recovery.
A feasibility trial, conducted in the spinal outpatient setting at anAustralianmetropolitan
hospital, is the crucial first step towards definitive testing of this intervention. The primary
aim of this study was to determine the feasibility of recruitment and retention, assessment
procedures, implementation and acceptability of theGLITtER intervention for LBP patients
attending a spinal outpatient clinic. Secondary objectives included the identification of
modifications needed in the design of a larger effectiveness trial and provision of data to
enable calculation of an appropriately powered sample for a subsequent effectiveness trial.
METHODS
Trial approval, registration and reporting
The Research Ethics Committees at the Royal Adelaide Hospital (protocol no. 150308)
and the University of South Australia (protocol no. 0000034887) provided approval for
this study. The full protocol was pre-registered on the Open Science Framework (https:
//osf.io/8zrq3/) and the trial was registered on the Australian and New Zealand Clinical
Trials Registry (http://www.anzctr.org.au, registration number: ACTRN12617000317392).
Trial registration included details of all items from the World Health Organisation Trial
Registration Data Set (see Supplemental File 1). This study has been reported according to
the CONSORT 2010 guideline for transparent and quality reporting of randomised pilot
and feasibility trials (http://www.consort-statement.org) (see Supplemental File 2).
Study design
This investigation was a prospective, quasi-randomised feasibility trial with longitudinal
follow-up, involving sampling of patients attending the Spinal Assessment Clinic (SAC).
The study also adopted an adaptive trial design, whereby modifications could be made
during its conduct with the purpose of increasing the probability of success of the study
procedure or the intervention. Adaptations were made during recruitment of the first
one-third of participants, as pre-specified in the protocol (https://osf.io/8zrq3/).
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Study setting and participants
The study was conducted in the SAC, which operates in the Spinal Outpatient Department
at a large metropolitan hospital in South Australia. The SAC is a Physiotherapist-led clinic
attended by patients who warrant non-urgent consultation, as identified by a paper-based
triage procedure prior to appointment scheduling. All patients aged between 18 and 75 years
who were scheduled to attend the SAC with a lumbar spine disorder were considered for
inclusion. To be eligible, patients were required to be able to speak and understand (verbal
and written) English and have access to recent images of their lumbar spine. Baseline
pain duration was not an eligibility consideration, however it was anticipated that patients
presenting to the SAC were likely to have experienced pain for longer than 3 months, based
on usual minimum timeframes for appointment scheduling. Patients with a history of
lumbar spine surgery were excluded.
Intervention
Participants allocated to the intervention group received a ‘GLITtER’ consultation,
integrated into the standard SAC consultation. Participants allocated to the control group
received a ‘standard consultation’. Full details of the consultations are provided in Table 1
in accordance with the TIDieR template for intervention description and replication (see
http://www.equator-network.org). In brief—a routine, or ‘standard’ consultation involves
comprehensive patient assessment, review and interpretation of relevant investigations
and discussion of management recommendations. A key objective of the patient-centered
interaction is identification of potential surgical candidates, or the guidance of patients
appropriate for continued conservative care towards community-based options. The
GLITtER consultation includes all components of the standard consultation but is enhanced
by the implementation of a standardised framework through which imaging findings are
interpreted (designed to optimise patient reassurance), includes provision of take-home
resource, emphasizes the need for an active recovery, and offers links to further information.
Staff training
Two SAC clinicians (clinicians 1 and 2) volunteered to deliver the GLITtER intervention
and were provided with training. Two clinicians (clinicians 3 and 4) remained naïve to
GLITtER and agreed to deliver the control intervention. A 3-stage training process was
conducted for clinicians 1 and 2. The initial stage involved ameeting to provide background,
rationale and an overview of the planned intervention. Within this session, a neurosurgeon
(YHY) led instruction and discussion of the imaging interpretation strategy developed
for GLITtER. The second stage involved providing clinicians 1 and 2 with the framework
for the GLITtER intervention, with instruction to undertake self-directed familiarization
with the content (see Supplemental File 3). The third stage was a face-to-face session with
the principal researcher to discuss the intervention framework and practice strategies for
clinical implementation. The total time for training and familiarisation was 2–2.5 h.
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Table 1 Description of the intervention and control consultations (consistent with the TIDieR reporting checklist (see www.equator-network.org)).
GLITtER consultation Standard consultation
WHY Goal: To supplement and enhance the standard SAC consultation with a
strategy designed to optimise patient reassurance and facilitate engagement in
an active recovery.
Goal: To provide comprehensive assessment and management of
patients with LBP attending the SAC. Key objectives are to identify
potential surgical candidates and to transfer the care of non-surgical
candidates to General Practitioner supported community based care
Bear, Orlando & Kumar (2016).
WHAT Materials:
• GLITtER Framework used for clinicians training (see Supplemental File 3)
• Visual aid A (used during intervention delivery): graph of prevalence of
degenerative features in asymptomatic adults (see Supplemental File 7)
• Take-home information resource (see Supplemental File 8). This
was designed as a series of 4 posters to be displayed one week at a time.
• Links to online information (incorporated into take-
home resource and delivered via smartphone text messages):
◦ The truth about back pain (https://
www.youtube.com/watch?v=b-cBtPSf0Hc)
◦ Tame the Beast (https://www.youtube.com/watch?v=ikUzvSph7Z4)
◦How to start exercising and stick to it (https://www.helpguide.org/
articles/healthy-living/how-to-start-exercising-and-stick-to-it.htm)
• Understanding pain in less than 5 min (https:
//www.youtube.com/embed/qEWc2XtaNwg)
• Letter to General Practitioner (see Supplemental File 9)
Materials:
• No physical or informational materials are routinely
used or provided
Procedures:
• All procedures implemented in the standard con-
sultation were included in the GLITtER consultation.
• Additional procedures (unique to the GLITtER consultation):
i. Provide detailed information about ‘normal’, age-
relevant imaging findings and involve visual aid A.
ii. In addition to explaining patient’s imaging findings, ex-
plain that: Scans (on their own) do not explain much about:
- Your current pain (e.g., why you have good days and bad).
- The activity you are capable of, or
- How likely you are to recover (because the changes on
your scans will still be there when your pain goes away)
iii. Re-interpret imaging findings, highlighting ‘positive’ features. E.g.
- Demonstrate spinal features that offer structural sta-
bility and emphasise the inherent strength of the spine.
- Demonstrate musculature and joints–structures
that need movement to be optimally healthy.
iv. Promote using the ‘TICK list’ as a strategy for increas-
ing planned activity/exercise (see Supplemental File 8).
v. Introduce patient to take-home information (see Supplemental File 8).
vi. Request patient completion of GLITtER checklist
(See Supplemental File 10) and discuss further if required.
vii. Text message follow-up: 4× (brief) weekly SMS messages prompted
participants to display/read the relevant poster, and provided an active link to
the online information recommended on the poster.
Procedures: A standard consultation involves:
• Subjective examination/patient history.
• Physical examination, including neurological assessment.
• Review of imaging and relevant investigations.
• Discussion of relevant findings (from
examination and investigations).
• Discussion of management recommendations.
•Written correspondence with the patients’ General Practitioner








GLITtER consultation Standard consultation
WHO PROVIDED Clinician 1 (Physiotherapist)
14 years clinical experience 7








13 years clinical experience








17 years clinical experience
1 years’ experience in SAC
Post-graduate (Masters) de-
gree Completed SAC Com-
petencies framework, partic-
ipates in weekly professional
development
Clinician 4 (Physiotherapist)
25 years clinical experience
7 years’ experience in SAC
Post-graduate (Masters) de-
gree Completed SAC Com-
petencies framework, partic-
ipates in weekly professional
development
HOW 1:1 delivery (integrated into individual patient consultation in the SAC).




Single session, integrated into a standard SAC consultation. Approxi-
mately 10 min’s duration (in addition to standard consultation).
Standard ‘new patient’ consultation in the SAC at the RAH.
Approximately 30–40 min duration.
TAILORING Patient-centred standard consultation (as noted). Imaging interpretation
tailored according to imaging findings. Exercise advice tailored according
to the patient’s age, physical condition, and practical considerations.
Patient-centred consultation with assessment, discussion and
management guided by the characteristics of the patient and their
clinical presentation.
MODIFICATIONS A visual aid developed for use during the consultation was considered to
be unnecessary.
Not applicable.
HOWWELL Intervention fidelity was not assessed. (This is an important
consideration for future effectiveness testing).
Not applicable.
Notes.
GLITtER, Green Light Imaging interpretation To Enhance Recovery; LBP, low back pain; SAC, Spinal Assessment Clinic; SMS, short message service.








The primary outcome of this study was the fulfillment of specific feasibility criteria that
were established a-priori (see Table 2) and designed to demonstrate that a subsequent
effectiveness trial would be likely to be acceptable (to both patients and clinicians) and
have sound methods and procedures likely to lead to successful trial completion. These
criteria were considered and reported under the domains of process, resource and scientific
considerations (Thabane et al., 2010) and acceptability. Process considerations referred to
steps essential for the success of a larger study including rates of participant recruitment
and retention. Resource considerations related to time and budget issues and included
participant and clinician burden. Scientific considerations included estimates of treatment
effect, variance of effect and data acquisition for a subsequent sample size calculation. We
classified criteria that met the standards specified in Table 2 as ‘‘achieved’’ and criteria that
failed to meet these pre-specified standards (and would need addressing or adapting before
proceeding with further testing of the intervention as ‘‘review’’.
The secondary outcomes of this study were:
(1) Attainment of data permitting calculation of an appropriately powered sample for a
subsequent RCT (i.e., the standard deviation of the NRS score for pain at 3-month
follow-up).
(2) Exploratory analysis of between-group differences for changes in pain, disability, and
kinaesiophobia (from baseline to 3 month follow-up).
(3) Identification of ceiling or floor effects.
(These outcomes were considered and reported under the domain of scientific
considerations.)
Sample size
We aimed to allocate 40 study participants to intervention or control groups using a quasi-
randomised procedure. This sample size was considered adequate for a feasibility study
(designed principally to assess feasibility of recruitment and procedures), and sufficient to
inform a power analysis for a subsequent randomised controlled trial (Hertzog, 2008).
Procedure
The full study procedure, including preliminary and primary screening procedures to
determine patient eligibility for participation, is outlined in Fig. 1.
Confirmation of participant eligibility
At completion of the SAC assessment, all clinicians completed a 5-item checklist to confirm
final eligibility for participation in this study. The intention of this checklist was to exclude
patients who required subsequent investigations, interventions or surgical intervention, or
patients who had pathology requiring significant caution with activity. It also confirmed
that patients had functional or exercise restrictions, such that an intervention to promote
activity was warranted. Participants meeting all criteria were notified of their inclusion in
the study and were informed regarding subsequent follow-up procedures.
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Table 2 Feasibility considerations, criteria and outcomes.
Feasibility considerations Criteria Outcome
Process
Recruitment rate One participant per clinician per (weekly) clinic can be
recruited (four participants recruited at each clinic)
Review
Consent rate At least 70% of all eligible patients can be recruited Achieved






95% completion of baseline data (Recommended
Minimum Dataset for LBP Research and TSK-11) prior
to SAC appointment
Review
Clinician/SAC burden consultations do not extend clinic appointments by
more than 10 min (on average)
Achieved
Acceptability
Patient acceptability >80% of responses to Questions 1–7 of the Participant





SAC Clinicians (delivering the GLITtER
intervention) report that they are ‘‘confident’’
or ‘‘very confident’’ when asked:
• ‘‘How confident are you that you
could integrate GLITtER into standard
practice on an ongoing basis?’’ and
• ‘‘How confident are you that integrating GLITtER
would enhance SAC care?’’ (4-point scale)
Achieved
Scientific
Determination of sample size
for appropriately powered
RCT
Use the standard deviation of the NRS score for pain at
3-month follow-up to calculate sample size
Achieved
Exploratory analyses of effect Calculate between-group differences for changes in
pain, disability, and kinaesiophobia (from baseline to 3
month follow-up)
Achieved




acriterion not pre-specified in protocol.
LBP, low back pain; TSK, Tampa Scale for Kinaesiophobia; SAC, Spinal Assessment Clinic; RCT, randomised controlled
trial.
Group allocation and participant blinding
Participants were allocated to the GLITtER Intervention or the control group via a
quasi-randomised procedure devised to cause minimal interference to clinic processes and
also allow between-group comparisons. Group allocation was determined by appointment
scheduling and clinician availability, such that patients were seen in order of their arrival
at the clinic by the first available clinician. Patients meeting the primary eligibility criteria
were thereby pragmatically allocated to the intervention or control conditions. Clinicians
1 and 2 were advised to provide no more than one GLITtER intervention per clinic session
to minimise potential time burden and disruption to clinic flow. Study participants were
unaware whether they received a GLITtER consultation or a standard consultation.
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Figure 1 StudyFlow: Prospective, comparative, feasibility trial of GLITtER. Abbreviations: TSK, Tampa
Scale for Kinaesiophobia; SMS, short message service; NRS, numeric rating scale; RMDQ, Roland Morris
Disability Questionnaire.
Full-size DOI: 10.7717/peerj.4301/fig-1
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Data collection
Baseline demographic and outcome data were hand-recorded by participants on purpose-
designed forms. Follow-up outcome data were obtained via completion of postal
questionnaires. All data were entered onto a password protected excel spreadsheet.
Participants were requested to complete the Recommended Minimum Data Set for LBP
Research (Deyo et al., 2014) and the Tampa Scale for Kinaesiophobia-11 (TSK-11) (Tkachuk
& Harris, 2012) at study inception. At 1 month follow-up, participants were mailed
numeric rating scales (NRS) for pain and disability, three questions about reassurance
(Supplemental File 4), and a participant experience questionnaire (Supplemental File 5).
At 3 month follow-up participants were requested to complete pain and disability NRS, the
Roland Morris Disability Questionnaire (RMDQ)(Roland & Morris, 1983), and the TSK-
11. Health care utilisation was also evaluated at 1 and 3 months (Supplemental File 5).
Interim study evaluation
Interim evaluation of the trial was undertaken after 30% of participants had been recruited
into the study. We considered problems with participant recruitment and discussed any
clinician concerns or suggestions. We also reviewed participant responses for completeness
and reports of intervention acceptability. Study protocol modifications were considered
and implemented as considered appropriate by the research team, and all changes were
recorded.
Statistical methods
Baseline clinical and demographic characteristics of the participants were reported using
descriptive statistics. Patient eligibility, recruitment and retention rates were calculated,
and reasons for refused consent were recorded where they were available. Questionnaire
completion rates were also calculated. The standard deviation of the primary outcome
measure to be used in a future effectiveness trial (pain NRS at 3months) was used to inform
the sample size calculation for a larger RCT. We planned to conduct exploratory analysis of
between-group differences in change scores for pain, disability and kinaesiophobia (from
baseline to 3-month follow-up) using ANOVA, acknowledging that estimates of treatment
effect should be assumed to be imprecise due to the non-randomised allocation procedure
and small sample size.
RESULTS
Baseline characteristics of participants
Thirty one patients were enrolled in this study between the 2nd March and the 14th July,
2017, with the trial ceased due to temporary closure of the service. Detailed baseline data
were collected for all participants consistent with the Recommended Minimum Dataset
for LBP research (Deyo et al., 2014) (see Supplemental File 6). Sixty-three percent of
study participants were female, and the mean age of participants was 50.1 years (standard
deviation (SD) 14.0, range 20–75 years). All participants reported experiencing LBP for
more than 6 months. Key baseline data are reported in Table 3.
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Table 3 Key baseline participant characteristics.





Age (mean, SD) 50.1 (14.0) 52.4 (11.7) 46.1 (17.4)
Gender (% female) 63% 65% 55%
Pain NRS (mean, SD): In the past 7 days,
how would you rate the intensity of your
pain on average? (Questions 3a)
6.3 (1.8) (97% complete
responses)
6.2 (1.8) (95% complete
responses)
6.5 (2.0) (100% complete
responses)
Disability NRS (mean, SD): In the past 7
days, how much has pain interfered with
your day-to-day activities? (Questions 7a)
5.8 (2.1) (100% complete
responses)
5.9 (1.8) (100% complete
responses)
5.6 (2.5) (100% complete
responses)
Pain Catastrophising Scale (mean, SD) 38.9 (7.3) (74% complete
responses)
40.5 (7.1) (65% complete
responses)
36.7 (7.3) (91% complete
responses)
Notes.
SD, standard deviation; NRS, numeric rating scale.
aFrom Recommended Minimum Dataset for Low Back Pain Research, see Supplemental Information 6.
Interim evaluation
Interim evaluation occurred after the first 12 participants had been recruited into the
trial. The main issue discussed was the failure to consistently meet the weekly target for
participant recruitment. An unforeseen change to clinic process (with the result that fewer
patients who were likely to be recommended for conservative management received SAC
appointments) was identified as the reason for the lower number of patients meeting the
final eligibility criteria than anticipated. While no significant resolution to this issue was
identified, the exclusion of patients who reported a past history of spinal surgery was
discussed. We recognised that many of these patients did not require further imaging or
surgical opinion and had the potential to benefit from GLITtER. The primary eligibility
criteria were revised to permit inclusion of participants who had had no more than 1
surgical procedure (more than 2 years prior) and who met all other inclusion criteria.
At this interim stage, follow-up data were available from five participants—three of
whom received a GLITtER Consultation. 100% of responses on the Participant Experience
Questionnaires were favourable (i.e., responded to the participant satisfaction statements
with ratings of ‘‘agree’’ or ‘‘strongly agree’’). Clinicians delivering the GLITtER intervention
also reported being satisfied with study processes. They perceived the GLITtER intervention
to be well accepted by patients and felt confident in their ability to deliver it time efficiently
and with competence. No specific concerns were raised.
Achievement of feasibility criteria
Achievement outcomes of the pre-specified feasibility are provided in Table 2 and detailed
below.
Process considerations
A total of 31 participants were recruited from 15 clinic sessions. A CONSORT flow diagram
detailing study recruitment is provided in Fig. 2. Of the 101 patients who met the primary
eligibility criteria, 24 patients declined involvement. This resulted in a consent rate of 75%,
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Figure 2 CONSORT flow diagram.
Full-size DOI: 10.7717/peerj.4301/fig-2
which was considered acceptable according to our pre-specified criteria. In addition to
this however, 8% did not complete signed consent forms due to unspecified reasons. An
average of two participants were recruited each clinic session, which wasmuch less than our
target recruitment rate of four participants per clinic session. Further consideration and
revision of recruitment feasibility is required. Acceptable participant follow-up response
rates were also not achieved, with 1 and 3-month outcome data available for 36% and 42%
of participants respectively.
Resource considerations
Participants completed 95%of all data items at baseline. 96%of items on the Recommended
Minimum Dataset were completed and 92% of items on the TSK-11 were completed.
Clinician burdenwas evaluated by the duration of theGLITtER consultations in comparison
with standard consultations. 54 SAC consultations (11 GLITtER consultations and 43
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Table 4 Baseline, 3 month follow-up and change scores for pain, disability and kinaesiophobia.









Pain (NRS) 6.2 (1.8) N = 19 6.5 (2.0) N = 7 6.5 (2.0) N = 11 5.3 (2.1) N = 6
Disability (NRS) 5.9 (1.8) N = 20 4.2 (2.8) N = 7 5.6 (2.5) N = 11 4.2 (2.9) N = 6
Kinaesio phobia
(TSK 11)
40.6 (7.1) N = 13 38.9 (7.2) N = 5 36.7 (7.3) N = 10 30.0 (7.8) N = 5
Notes.
SD, standard deviation; NRS, numeric rating scale; TSK, Tampa Scale for Kinaesiophobia.
Standard Consultations) were timed by clinicians 1 and 2. The mean duration of the
GLITtER consultations was 41 min (SD= 7, minimum 30, maximum 50). The mean
duration of standard consultations was 40 min (SD= 9 min, minimum 25, maximum 70).
Three of the standard consultations exceeded 50 min. If these consultations were excluded,
the mean duration of the Standard Consultations was reduced to 39 min (SD= 7).
Management considerations
100% of responses on the participant experience questionnaires (for participants who
received a GLITtER consultation) were favourable (i.e., participants responded to the
satisfaction statements with ratings of ‘‘agree’’ or ‘‘strongly agree’’). Clinicians 1 and 2
both reported that they were ‘‘confident’’ that they could integrate GLITtER into standard
practice on an ongoing basis (on a 4-point Likert scale ranging from ‘‘not at all confident’’
to ‘‘very confident’’). One clinician was ‘‘very confident’’ and the other was ‘‘confident’’
that integrating GLITtER into routine consultations would enhance SAC care.
Scientific considerations
Based on a linear mixed effects model with two time points (baseline and 3 months),
power= 80%, Type 1 error= 5%, an expected correlation between baseline and 3 months
measurements of 0.5, a MCID of 1, and a SD of 2.1, then 53 patients are required per
group. Allowing for 15% loss to follow-up, a sample size of 63 participants per group is
required for an appropriately powered RCT.
Mean pain, disability, and kinaesiophobia scores at baseline and 3 month follow-up are
provided in Table 4. We did not calculate change scores or conduct exploratory analysis of
between-group differences (as specified a priori) due to the small sample sizes achieved in
each group. No ceiling or floor effects were observed.
DISCUSSION
This investigation has highlighted some important operational challenges impacting the
feasibility of successfully conducting a future effectiveness trial of GLITtER (Green Light
Imaging Interpretation to Enhance Recovery). While pre-specified targets for consent
rates, resource burden and acceptability of the GLITtER intervention were met, participant
recruitment was slower than anticipated and an acceptable follow-up rate was not achieved.
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Recruitment of participants into the study occurred at half of the anticipated rate, due
largely to fewer patients meeting the final eligibility criteria than expected. An identified
contributor to this was the change to referral management processes such that patients who
were unlikely to be candidates for intervention were no longer offered SAC appointments.
(Instead, these patients and their General Practitioners were informed via a letter that
community-based management was most appropriate.) Although the number of patients
attending the SAC who were eligible for this study was low, this may not indicate that
the number of individuals suitable for the GLITtER intervention is also low. Instead, it
may indicate that there is need to further consider how best to access the patients for
whom GLITtER may offer potential benefit. Alternatively, plans to further investigate the
GLITtER intervention in the spinal outpatient setting must carefully consider patient triage
procedures, allow for slower recruitment, and investigate the potential for recruitment at
multiple sites. The wording on the information sheet should also be reconsidered to avoid
the risk that some patients may have declined participation out of concern that they would
be given reassuring information during their consultation, rather than the information
that they were seeking.
We achieved a 3-month participant follow-up rate of only 42%, which failed to meet our
feasibility criterion. In hindsight, our objective to achieve complete follow-up data from
95% response rate was high—a drop-out rate of more than 20% is generally considered to
compromise the validity of a clinical trial unacceptably (Schulz & Grimes, 2002). Possible
reasons for the high drop-out rate may have included participant improvement (such that
LBP was no longer a significant concern), or patient perceptions of a lack of relevance of the
intervention or the follow-up requests. The protocol for collecting follow-up data via postal
questionnaires and SMS reminders was based on the procedure applied in our previous
work, which achieved a 4 month follow-up rate of 89% (Karran et al., 2017b). There were
two main differences in the follow-up conditions between these studies. Firstly, our prior
study involved participants while they were still waiting for their clinic appointments to
be scheduled which may have facilitated engagement, whereas follow-up for the current
trial occurred after patients had received their clinic consultation. Secondly, for our initial
study, we sent small packets of confectionery with requests for completion and return
of questionnaires, whereas in the current trial we did not. Future investigations in this
setting should further consider developing an enhanced protocol for achieving follow-up
targets and providing participant incentives (Brueton et al., 2013). It may also be important
to consider revision of the inclusion criteria to ensure that the patient’s problem is of
sufficient severity to warrant engagement with the study. Unfortunately, the poor response
rate attained in this study impacted the achievement of our secondary objectives. Collected
data were used to cautiously inform the determination of sample size for a larger RCT, but
was considered insufficient to undertake exploratory analysis of effect.
The GLITtER intervention was acceptable, of perceived benefit to both patients and
clinicians, and was able to be integrated into a standard consultation without significant
time burden for clinicians. The 95% data completion rate on the recommended minimal
dataset for LBP research (Deyo et al., 2014) suggests that despite its length, it is not overly
onerous for participants. The consent rate of 75% exceeded our target rate, however it must
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be acknowledged that a further 8% of patients who met the primary eligibility criteria did
not either confirm or decline consent. Whilst a number of these exclusions were likely to be
related to procedural or timing issues it must be also considered that some of these patients
may have opted out of the study (without this action being recorded)—with impact on the
overall consent rate.
This study employed rigorous scientific methods throughout. The protocol was
developed in accordance with the SPIRIT checklist and pre-registered on Open Science
Framework. The trial was registered on theANZCTR and has been reported according to the
CONSORT statement. Description of the GLITtER intervention followed the TIDieR rec-
ommendations for reporting of clinical interventions and theNIHs task force recommended
minimum data set for LBP clinical trials was implemented. The specification of feasibility
criteria prior to conducting this investigation is a further strength of this study’s design.
Several weaknesses have also been recognised. There are no standardised criteria for
evaluating feasibility, or how achievement of the established criteria should be measured.
We used an evidence-informed but ultimately investigator-led approach to identify
and quantify our feasibility criteria, which may not have been optimal. Factors such as
participant adherence to management recommendations and investigator burden could
also have been considered. In addition, we consider that the ability to engage clinicians
and administrative personnel is imperative to the success of a clinical trial but we did not
formally assess engagement. Our sample size and our follow-up rate were smaller than we
expected, which resulted in less data to evaluate our feasibility criteria than we specified
as a requirement a priori. The study sample may therefore not be representative of the
larger patient population, raising the risk that estimates or interpretations that arise lack
precision or are potentiallymisleading. Last, staff training was not formalised and treatment
fidelity was not assessed. While we did calculate an estimated sample size required for a
RCT to definitively examine the effect of the GLITtER intervention, this result should be
interpreted with caution. Encouragingly, the baseline value for the pain NRS score and the
standard deviation of this measure at 3-month follow-up, were very similar to the data
recorded in another LBP feasibility trial on which a sample size estimate was also based
(Ellard et al., 2017). Based on the assumption that two participants from each SAC would
meet final eligibility criteria for inclusion in the study and be randomised, and that clinics
operate on 46 weeks of the year—it appears realistic that 92 participants could be recruited
annually. Timely achievement of a recruitment target of 126 is likely to be possible, and
potential also exists to consider enrolment of participants at two or more sites.
This study successfully tested for feasibility of a highly pragmatic approach to addressing
the clinical challenge of providing time-efficient, low cost, guideline-informedmanagement
of patients with LBP attending secondary care. Based on analysis of our feasibility criteria, a
full-scale RCT evaluating the effectiveness of theGLITtER intervention is not recommended
without considering strategies that are capable of resolving the recruitment and follow-up
issues that we have identified. The shift in clinical pathways raises the possibility that
testing of GLITtER in primary care may be indicated. These issues are likely to affect other
trials in this population and as such, we humbly suggest that the lessons we have learnt be
considered recommendations for the field.
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CONCLUSIONS
Failure to achieve pre-specified recruitment and follow-up rates was disappointing,
however these were important outcomes of a feasibility study. It is realistic to consider that
these challenges can be overcome through careful strategy, ample funding and continued
partnership with health care providers.
ACKNOWLEDGEMENTS
The authors gratefully acknowledge the cooperation and contributions of staff from
the Royal Adelaide Hospital Spinal Unit, Spinal Assessment Clinic and Physiotherapy
Departments who made this study possible. We also express our thanks to the patients
involved.
ADDITIONAL INFORMATION AND DECLARATIONS
Funding
Emma L. Karran was supported by the Royal Adelaide Hospital Research Foundation
Clinical Research Grant (2015) and the Royal Adelaide Hospital Research Foundation
Dawes Scholarship (2016–2018). G. Lorimer Moseley is supported by the National Health
and Medical Research Council (NHMRC), Australia (ID: 106279). The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Grant Disclosures
The following grant information was disclosed by the authors:
The Royal Adelaide Hospital Research Foundation Clinical Research Grant (2015).
The Royal Adelaide Hospital Research Foundation Dawes Scholarship (2016–2018).
The National Health and Medical Research Council (NHMRC), Australia: 106279.
Competing Interests
G. Lorimer Moseley has received support from Pfizer Australia, Workers’ Compensation
Boards in Australia, North American and Europe, NOIgroup Australasia, Kaiser
Permanente California, Results Physiotherapy, Agile Physiotherapy, the International
Olympic Committee and the Port Adelaide Football Club, and receives royalties from
the following books: Explain Pain; Explain Pain Handbook: Protectometer; Explain Pain
Supercharged; Painful Yarns—Metaphors and Stories to Help Understand the Biology of
Pain; the Graded Motor Imagery Handbook. All other authors declare that they have no
competing interests.
Author Contributions
• Emma L. Karran conceived and designed the experiments, analyzed the data, wrote the
paper, prepared figures and/or tables, provided training for clinical staff.
• Susan L. Hillier conceived and designed the experiments, analyzed the data, reviewed
drafts of the paper.
Karran et al. (2018), PeerJ, DOI 10.7717/peerj.4301 16/20
• Yun-Hom Yau conceived and designed the experiments, analyzed the data, reviewed
drafts of the paper, provided training for clinical staff.
• James H. McAuley and G. Lorimer Moseley conceived and designed the experiments,
reviewed drafts of the paper.
Clinical Trial Ethics
The following information was supplied relating to ethical approvals (i.e., approving body
and any reference numbers):
The Research Ethics Committees at the Royal Adelaide Hospital (protocol no. 150308)
and the University of South Australia (protocol no. 0000034887) provided approval for
this research.
Clinical Trial Registration
The following information was supplied regarding Clinical Trial registration:
Australian and New Zealand Clinical Trials Registry: ACTRN12617000317392.
Supplemental Information
Supplemental information for this article can be found online at http://dx.doi.org/10.7717/
peerj.4301#supplemental-information.
REFERENCES
ABS. 2015. AIHW analysis of unpublished ABS Australian Health Survey, 2014–2015.
Available at www.aihw.gov.au/back-problems/prevalence/#source-table5.
Bear M, Orlando JF, Kumar S. 2016. Overcoming the tyranny of distance: An audit of
process and outcomes from a pilot telehealth spinal assessment clinic. Journal of
Telemedicine and Telecare 23(8):733–739 DOI 10.1177/1357633X16664851.
Brinjikji W, Luetmer P, Comstock B, Bresnahan B, Chen L, Deyo R, Halabi S, Turner J,
Avins A, James K. 2014. Systematic literature review of imaging features of spinal
degeneration in asymptomatic populations. American Journal of Neuroradiology
36:811–816 DOI 10.3174/ajnr.A4173.
Brueton VC, Tierney J, Stenning S, Harding S, Meredith S, Nazareth I, Rait G.
2013. Strategies to improve retention in randomised trials. The Cochrane Library
2013(12):Article MR000032 DOI 10.1002/14651858.MR000032.pub2.
Carragee E, Alamin T, Cheng I, Franklin T, Van den Haak E, Hurwitz E. 2006. Are first-
time episodes of serious LBP associated with new MRI findings? The Spine Journal
6:624–635 DOI 10.1016/j.spinee.2006.03.005.
Carragee EJ, Alamin TF, Miller JL, Carragee JM. 2005. Discographic, MRI and psy-
chosocial determinants of low back pain disability and remission: a prospective
study in subjects with benign persistent back pain. The Spine Journal 5:24–35
DOI 10.1016/j.spinee.2004.05.250.
Coulter A. 1998.Managing demand: managing demand at the interface between primary
and secondary care. British Medical Journal 316:1974–1976
DOI 10.1136/bmj.316.7149.1974.
Karran et al. (2018), PeerJ, DOI 10.7717/peerj.4301 17/20
De Schepper EI, Koes BW, Oei EH, Bierma-Zeinstra SM, Luijsterburg PA. 2016. The
added prognostic value of MRI findings for recovery in patients with low back
pain in primary care: a 1-year follow-up cohort study. European Spine Journal
25:1234–1241 DOI 10.1007/s00586-016-4423-6.
Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino
J, Chou R, Cook K, DeLitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis
J, Rainville J, Tosteson T, Turk D, Von Korff M,Weiner DK. 2014. Report of the
NIH task force on research standards for chronic low back pain. The Journal of Pain
15:569–585 DOI 10.1016/j.jpain.2014.03.005.
Ellard DR, Martin U, Felix A, James HLA, Shyam B, Sally B, Melinda C, James G,
Frances G, Kirstie H, Charles H, Ranjit L, Stavros P, Nigel S, Colin T, David AW,
Sandhu H. 2017. Facet joint injections for people with persistent non-specific low
back pain (Facet Injection Study): a feasibility study for a randomised controlled
trial. Health Technology Assessment 21:1–184 DOI 10.3310/hta21300.
Graves JM, Fulton-Kehoe D, Jarvik JG, Franklin GM. 2012. Early imaging for acute
low back pain: one-year health and disability outcomes among Washington State
workers. Spine 37:1617–1627 DOI 10.1097/BRS.0b013e318251887b.
HasenbringMI, Pincus T. 2015. Effective reassurance in primary care of low back pain:
what messages from clinicians are most beneficial at early stages? Clinical Journal of
Pain 31:133–136 DOI 10.1097/AJP.0000000000000097.
HertzogMA. 2008. Considerations in determining sample size for pilot studies. Research
in Nursing & Health 31:180–191 DOI 10.1002/nur.20247.
Jensen OK, Nielsen CV, Sorensen JS, Stengaard-Pedersen K. 2014. Type 1 Modic
changes was a significant risk factor for 1-year outcome in sick-listed low back pain
patients: a nested cohort study using magnetic resonance imaging of the lumbar
spine. Spine Journal 14:2568–2581 DOI 10.1016/j.spinee.2014.02.018.
Karran EL, McAuley JH, Traeger AC, Hillier SL, Grabherr L, Russek LN, Moseley
GL. 2017a. Can screening instruments accurately determine poor outcome risk in
adults with recent onset low back pain? A systematic review and meta-analysis. BMC
Medicine 15:13 DOI 10.1186/s12916-016-0774-4.
Karran EL, Traeger AC, McAuley JH, Hillier SL, Yau Y-H, Moseley GL. 2017b. The
value of prognostic screening for patients with low back pain in secondary care. The
Journal of Pain 18:673–686 DOI 10.1016/j.jpain.2016.12.020.
Karran E, Yau Y, Hillier S, Moseley GL. 2018. The reassuring potential of spinal
imaging results: development and testing of a brief, psycho-education interven-
tion for patients attending secondary care. European Spine Journal 27:101–108
DOI 10.1007/s00586-017-5389-8.
Koes BW, Van Tulder M, Lin C-WC,Macedo LG, McAuley J, Maher C. 2010. An
updated overview of clinical guidelines for the management of non-specific low back
pain in primary care. European Spine Journal 19:2075–2094
DOI 10.1007/s00586-010-1502-y.
Li A, Yen D. 2010. Changes in referral pattern to a surgeon for low back pain: 1996 versus
2009. Healthcare Quarterly 13:91–95 DOI 10.12927/hcq.2010.21822.
Karran et al. (2018), PeerJ, DOI 10.7717/peerj.4301 18/20
Morsø L, Kent P, Albert HB, Manniche C. 2013. Is the psychosocial profile of people
with low back pain seeking care in Danish primary care different from those in
secondary care?Manual Therapy 18:54–59 DOI 10.1016/j.math.2012.07.002.
Morsø L, Kent P, Manniche C, Albert HB. 2014. The predictive ability of the STarT
back screening tool in a Danish secondary care setting. European Spine Journal
23:120–128 DOI 10.1007/s00586-013-2861-y.
(NICE) NIFHACE. 2016. Low back pain and management in over 16s: assessment
and management. Available at https://www.nice.org.uk/ guidance/ng59/ chapter/
Recommendations (accessed on 25 July 2017).
O’Connell NE, Cook CE,Wand BM,Ward SP. 2016. Clinical guidelines for low
back pain: a critical review of consensus and inconsistencies across three ma-
jor guidelines. Best Practice & Research Clinical Rheumatology 30:968–980
DOI 10.1016/j.berh.2017.05.001.
Pincus T, McCracken LM. 2013. Psychological factors and treatment opportunities
in low back pain. Best Practice & Research Clinical Rheumatology 27:625–635
DOI 10.1016/j.berh.2013.09.010.
Qaseem A,Wilt TJ, McLean RM, Forciea MA. 2017. Noninvasive treatments for acute,
subacute, and chronic low back pain: a clinical practice guideline from the American
college of physiciansnoninvasive treatments for acute, subacute, and chronic low
back pain. Annals of Internal Medicine 166:514–530 DOI 10.7326/M16-2367.
Robarts S, Stratford P, Kennedy D, Malcolm B, Finkelstein J. 2017. Evaluation of an
advanced-practice physiotherapist in triaging patients with lumbar spine pain:
surgeon–physiotherapist level of agreement and patient satisfaction. Canadian
Journal of Surgery 60:266–271 DOI 10.1503/cjs.013416.
RolandM,Morris R. 1983. A study of the natural history of back pain: part I: devel-
opment of a reliable and sensitive measure of disability in low-back pain. Spine
8:141–144 DOI 10.1097/00007632-198303000-00004.
RolandM, Van Tulder M. 1998. Should radiologists change the way they report plain
radiography of the spine? The Lancet 352:229–230
DOI 10.1016/S0140-6736(97)11499-4.
Schulz KF, Grimes DA. 2002. Sample size slippages in randomised trials: exclusions and
the lost and wayward. The Lancet 359:781–785
DOI 10.1016/S0140-6736(02)07882-0.
Sears ED, Caverly TJ, Kullgren JT, Fagerlin A, Zikmund-Fisher BJ, Prenovost K, Kerr
EA. 2016. Clinicians’ perceptions of barriers to avoiding inappropriate imaging for
low back pain-knowing is not enough. JAMA Internal Medicine 176:1866–1868
DOI 10.1001/jamainternmed.2016.6364.
Steffens D, HancockMJ, Maher CG,Williams C, Jensen TS, Latimer J. 2014. Does
magnetic resonance imaging predict future low back pain? A systematic review.
European Journal of Pain 18:755–765 DOI 10.1002/j.1532-2149.2013.00427.x.
Stochkendahl MJ, Kjaer P, Hartvigsen J, Kongsted A, Aaboe J, AndersenM, Andersen
MØ, Fournier G, Højgaard B, JensenMB. 2017. National clinical guidelines for
Karran et al. (2018), PeerJ, DOI 10.7717/peerj.4301 19/20
non-surgical treatment of patients with recent onset low back pain or lumbar
radiculopathy. European Spine Journal 27:60–75 DOI 10.1007/s00586-017-5099-2.
Suri P, Boyko EJ, Goldberg J, Forsberg CW, Jarvik JG. 2014. Longitudinal associations
between incident lumbar spine MRI findings and chronic low back pain or radicular
symptoms: retrospective analysis of data from the longitudinal assessment of imaging
and disability of the back (LAIDBACK). BMCMusculoskeletal Disorders 15:152
DOI 10.1186/1471-2474-15-152.
Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, ThabaneM, Gold-
smith CH. 2010. A tutorial on pilot studies: the what, why and how. BMCMedical
Research Methodology 10:Article 1 DOI 10.1186/1471-2288-10-1.
Tkachuk GA, Harris CA. 2012. Psychometric properties of the tampa scale for
kinesiophobia-11 (TSK-11). The Journal of Pain 13:970–977
DOI 10.1016/j.jpain.2012.07.001.
Traeger AC, Hübscher M, Henschke N, Moseley GL, Lee H, McAuley JH. 2015. Effect
of primary care-based education on reassurance in patients with acute low back
pain: systematic review and meta-analysis. JAMA Internal Medicine 175:733–743
DOI 10.1001/jamainternmed.2015.0217.
Traeger AC, O’Hagan ET, Cashin A, McAuley JH. 2017. Reassurance for patients with
non-specific conditions—a user’s guide. Brazilian Journal of Physical Therapy
21:1–6 DOI 10.1016/j.bjpt.2016.12.007.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC,
Charlson FJ, Chen AZ. 2016. Global, regional, and national incidence, prevalence,
and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic
analysis for the global burden of disease study 2015. The Lancet 388:1545–1602
DOI 10.1016/S0140-6736(16)31678-6.
Webster BS, Cifuentes M. 2010. Relationship of early magnetic resonance imaging
for work-related acute low back pain with disability and medical utilization
outcomes. Journal of Occupational and Environmental Medicine 52:900–907
DOI 10.1097/JOM.0b013e3181ef7e53.
Wong JJ, Côté P, Sutton DA, Randhawa K, Yu H, Varatharajan S, Goldgrub R, Nordin
M, Gross DP, Shearer HM, Carroll LJ, Stern PJ, Ameis A, Southerst D, Mior S,
Stupar M, Varatharajan T, Taylor-Vaisey A. 2017. Clinical practice guidelines for
the noninvasive management of low back pain: a systematic review by the Ontario
Protocol for Traffic Injury Management (OPTIMa) collaboration. European Journal
of Pain 21:201–216 DOI 10.1002/ejp.931.
Karran et al. (2018), PeerJ, DOI 10.7717/peerj.4301 20/20
